DexCom
Trade DexCom 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About DXCM
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE.
DXCM Key Statistics
Stock Snapshot
DexCom(DXCM) stock is priced at $83.37, giving the company a market capitalization of 31.2B. It carries a P/E multiple of 34.46.
During the trading session on 2026-08-05, DexCom(DXCM) shares reached a daily high of $87.02 and a low of $82.30. At a current price of $83.37, the stock is +1.3% higher than the low and still -4.2% under the high.
Trading volume for DexCom(DXCM) stock has reached 6.01M, versus its average volume of 6.02M.
The stock's 52-week range extends from a low of $54.11 to a high of $87.85.
The stock's 52-week range extends from a low of $54.11 to a high of $87.85.
DXCM News
DexCom (DXCM) drew fresh attention after reporting second quarter 2026 results with higher sales and earnings, and raised full year revenue guidance to a range...
Argus analyst Steve Silver raised the firm’s price target on DexCom (DXCM) to $96 from $86 and keeps a Buy rating on the shares. DexCom’s strong Q2 execution an...
In recent trading, shares of DexCom Inc (Symbol: DXCM) have crossed above the average analyst 12-month target price of $86.11, changing hands for $87.31/share....
Analyst ratings
84%
of 31 ratingsMore DXCM News
Image source: The Motley Fool. Thursday, July 30, 2026 at 4:30 p.m. ET CALL PARTICIPANTS senior vice president of finance and investor relations - Sean Christen...
In late July 2026, DexCom, Inc. reported second-quarter results showing revenue of US$1,308.4 million and net income of US$249.1 million, and raised its full-ye...
DexCom stock rose 12% to US$83.45 after earnings, a sharp move for a large medical device company that has already delivered strong multi month gains. The headl...
DexCom stock has delivered a roughly 43.1% decline over the past five years, yet an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach curr...
DexCom, Inc. DXCM reported second-quarter 2026 adjusted earnings per share (EPS) of 70 cents, which beat the Zacks Consensus Estimate of 61 cents by 14.8%. The...
Dexcom, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Josh Jennings from TD Cowen reiterated a Buy rating on the stoc...
(RTTNews) - DexCom Inc. (DXCM) reported a profit for its second quarter that Increases, from last year The company's earnings totaled $249.1 million, or $0.64...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.